Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vernakalant vs Flecainide for Cardioversion of Paroxysmal Atrial Fibrillation
NCT03005366Phase 4Completed
- Start
- Jan 2017
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vernakalant in Atrial fibrillation (AFib). Started Jan 2017; status: completed.
02
Drugs
vernakalant
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03005366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005366.